이 정보는 교육 목적으로만 제공됩니다. 반드시 의료 전문가와 상담하시기 바랍니다. 자세히 알아보기

Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent

Prescription

상품명: PNV-DHA

제형
Tablet
투여 경로
ORAL

About This Medication

DESCRIPTION PNV-DHA + Docusate is a prescription prenatal/postnatal multivitamin/multimineral softgel with DHA. Each softgel is red in color and imprinted with “323” on one side. † Daily Value (DV) not established. SUPPLEMENT FACTS Serving Size: 1 softgel Amount Per Serving % Daily Value Vitamin C (as ascorbic acid, USP) 28 mg 47% Calcium (tribasic calcium phosphate, NF) 160 mg 16% Iron (as ferrous fumarate, USP) 27 mg 150% Vitamin D 3 (as cholecalciferol, USP) 400 IU 100% Vitamin E (as d-alpha-tocopherol acetate, USP) 30 IU 100% Vitamin B 6 (as pyridoxine HCl, USP) 25 mg 1250% Folic Acid, USP 1.25 mg 313% DHA (docosahexaenoic acid) 300 mg † Docusate sodium, USP 55 mg † OTHER INGREDIENTS Bovine Gelatin, Glycerin, Soybean Oil, Soy Lecithin, Purified Water, Yellow Beeswax, FD&C Red # 40, Titanium Dioxide, Orange Cream Flavor, Ethyl Vanillin, FD&C Yellow # 6, and FD&C Blue #1. Contains soy. INDICATIONS PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

유효 성분

성분 함량
.Alpha.-Tocopherol Acetate, Dl- -
Ascorbic Acid -
Calcium -
Cholecalciferol -
Doconexent -
Ferrous Fumarate -
Folic Acid -
Pyridoxine -

적응증 및 용법

INDICATIONS PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

용량 및 투여 방법

DOSAGE AND ADMINISTRATION Usual adult dose is one (1) softgel daily or as directed by a physician. KEEP OUT OF REACH OF CHILDREN.

Side Effects Overview

ADVERSE REACTIONS Allergic sensitization has been reported following both oral and parenteral administration of folic acid. CAUTION: Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 grams (1000 mg) daily.

경고 및 주의 사항

금기

Frequently Asked Questions

INDICATIONS PNV-DHA + Docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

DOSAGE AND ADMINISTRATION Usual adult dose is one (1) softgel daily or as directed by a physician. KEEP OUT OF REACH OF CHILDREN.

WARNING Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Ascorbic Acid, Cholecalciferol, .Alpha.-Tocopherol Acetate, Dl-, Pyridoxine, Folic Acid, Calcium, Ferrous Fumarate, Doconexent is a prescription medication. You will need a valid prescription from a licensed healthcare provider.

Similar Tablet Products

Browse all Tablet products →

References & Data Sources

의료 면책 조항

이 페이지의 정보는 교육 목적으로만 제공되며, 전문적인 의학적 조언, 진단 또는 치료를 대체하는 용도로 사용해서는 안 됩니다.

의학적 상태나 의약품에 관한 질문이 있으시면 반드시 의사 또는 자격을 갖춘 의료 전문가에게 조언을 구하시기 바랍니다.

데이터 출처: DailyMed (NLM), openFDA, MFDS

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.